Novo Nordisk Insulin Revenue Drives 1Q Profits
May 1 (Bloomberg) -- Bloomberg Europe business correspondent Caroline Hyde reports that Novo Nordisk A/S announced a 28 percent increase in first-quarter profit as sales climbed for its insulins and the Victoza diabetes treatment. She speaks on Bloomberg Television's "The Pulse."
Most Recent Videos
Bloomberg Markets Trump: First 100 Days 4/21
44:55 - Guests include: Jacob Frenkel, JPMorgan Chase International chairman, Alice Rivlin, Brookings Institution senior fellow and Sweden's Finance Minister Magdalena Andersson. (Source: Bloomberg)